Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk by 42% in Phase 3 Trial
Phase 3 trial results presented at ESMO 2026 show that adding personalized mRNA vaccine intismeran to pembrolizumab reduces melanoma recurrence ...
Phase 3 trial results presented at ESMO 2026 show that adding personalized mRNA vaccine intismeran to pembrolizumab reduces melanoma recurrence ...
A nationwide ecological study of over four million cancer cases in China finds that long-term ambient ultraviolet radiation shows lag-, ...
A computational polarimetric imaging framework combining differential Mueller matrix decomposition, wide-field image stitching and pseudo-color visualization revealed depolarization as a ...
A UK Biobank study of 281,282 adults links longer outdoor sunlight exposure to higher risks of melanoma, obesity, and cerebrovascular ...
A review finds that fungal compounds can suppress tumour growth, alter immunity and limit metastasis in skin-cancer models, but manufacturing, ...
A retrospective Mayo Clinic study found that the DEXI dermoscopy AI tool, using a threshold score of 3.0, correctly identified ...
A synthetic enzyme produced pyruvate inside cancer-cell mitochondria, increased oxidative metabolism, altered growth-related gene expression and slowed human melanoma xenografts ...
A first small clinical study found encouraging tumor control, symptom relief and tolerability with minibeam radiotherapy in 36 patients with ...
Network analysis and B16F0 cell experiments linked carboplatin with CDKN1A, BRCA1, PTEN and AKT1 in melanoma, without establishing clinical benefit.
Three deep learning architectures trained on dermoscopic images reached the same band of accuracy yet differed by more than fourfold ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine